© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Novel Oral Antiobesity Drug Reduces Body Weight by up to 13%: Daily Dose
October 01, 2024
Your daily dose of the clinical news you may have missed.
FDA Approves First Self-Administered Flu Vaccine: Daily Dose
September 30, 2024
Your daily dose of the clinical news you may have missed.
Menopausal Hormone Therapy Use Declined in Past 2 Decades among Women Regardless of Age, Race/Ethnicity
September 27, 2024
Use of menopausal hormone therapy decreased from nearly 27% to 5% among postmenopausal women between 1999 and 2020, according to new research.
Better CV Health in Early Pregnancy Offsets High Genetic Risk: Daily Dose
September 27, 2024
Your daily dose of the clinical news you may have missed.
7 Drugs Approved for Primary Care: Q3 2024
September 26, 2024
Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.
Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose
September 26, 2024
Your daily dose of the clinical news you may have missed.
Roflumilast Cream 0.15% Leads to Consistent Improvements in Atopic Dermatitis Across Diverse Skin Types
September 25, 2024
Roflumilast cream 0.15% was associated with consistent and meaningful improvements in AD clearance and itch reduction, according to new data.
Over Half of US Adults with Uncontrolled HTN Unaware of Their Condition: Daily Dose
September 25, 2024
Your daily dose of the clinical news you may have missed.
Elinzanetant for Menopausal VMS: OASIS Lead Investigator Discusses Results, Side Effects, Next Steps
September 24, 2024
JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.
FDA Approves Lebrikizumab-lbkz for Moderate to Severe AD: Daily Dose
September 24, 2024
Your daily dose of the clinical news you may have missed.